Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.60 | 1.22 | 0.62 |
Shares | 99.39 | 99.41 | 0.02 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.78 | 20.57 |
Price to Book | 4.31 | 4.17 |
Price to Sales | 2.40 | 2.47 |
Price to Cash Flow | 17.33 | 17.02 |
Dividend Yield | 1.83 | 1.35 |
5 Years Earnings Growth | 13.15 | 13.68 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.58 | 94.95 |
Basic Materials | 0.32 | 1.64 |
Consumer Defensive | 0.06 | 3.73 |
Financial Services | 0.04 | 10.15 |
Number of long holdings: 186
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.67 | 794.14 | -0.19% | |
UnitedHealth | US91324P1021 | 6.67 | 511.15 | +1.00% | |
J&J | US4781601046 | 4.97 | 145.58 | -0.19% | |
AbbVie | US00287Y1091 | 4.65 | 179.20 | -0.44% | |
Novo Nordisk B | DK0062498333 | 4.42 | 622.6 | +5.67% | |
Merck&Co | US58933Y1055 | 3.31 | 99.87 | +0.42% | |
Roche Holding Participation | CH0012032048 | 2.86 | 251.00 | +1.46% | |
Novartis | CH0012005267 | 2.84 | 87.68 | +1.11% | |
Thermo Fisher Scientific | US8835561023 | 2.70 | 527.18 | -0.34% | |
Abbott Labs | US0028241000 | 2.54 | 115.27 | +0.44% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust C Acc | 8.38B | 27.84 | 12.09 | 15.28 | ||
Legal General US Index Trust C Dist | 8.38B | 27.74 | 12.07 | 15.27 | ||
Legal General US Index Trust F Acc | 8.38B | 27.45 | 11.76 | 14.94 | ||
Legal General US Index Trust F Dist | 8.38B | 27.39 | 11.74 | 14.94 | ||
Legal General US Index Trust I Acc | 8.38B | 27.75 | 12.04 | 15.23 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review